Curant Health and the 2016 American College of Gastroenterology Annual Scientific Meeting


Curant Health and Johns Hopkins University present Project A.L.I.V.E. interim study results.

View our poster that was presented at ACG 2016 on Monday, October 17.

“Do you take your IBD medicine? Assessing the effect of a patient fulfillment model on medication adherence.”

Dr. Sharon Dudley-Brown, Principal Investigator, Assistant Professor of Medicine; Director of Clinical Services, Vickie Andros, PharmD. and Krystin Tran, PharmD.

Curant Health was proud to present study results to date with Dr. Sharon Dudley-Brown of Johns Hopkins at this year’s recent ACG 2016. First announced September 2014, Curant Health, provider of enhanced medication therapy management and specialty pharmacy services, is conducting a study with the Meyerhoff Inflammatory Bowel Disease Center of the Johns Hopkins University School of Medicine to “implement and evaluate the effectiveness of an Inflammatory Bowel Disease (IBD) Medication Therapy Management (MTM) patient fulfillment model compared to standard care in a large university hospital setting.”

The team is evaluating results at 30 days, 60 days, six months, nine months and 12 months from the initiation of the IBD MTM patient fulfillment model.

The study’s abstract is available here.

What are the study objectives?

To improve symptoms as measured by the Dudley IBD Symptom Questionnaire (DISQ) and quality of life as measured by the Short Inflammatory Bowel Disease Questionnaire (SIBDQ)

  • To decrease hospital readmission rates for patients with IBD
  • To improve adherence rates for IBD therapy
  • To assess smoking rates among these patients with IBD

Why is it important to look at MTM and its effects on adherence rates for patients with IBD?

Increasingly recognized in the healthcare community is the absence of long-run reports on CD or UC. Therefore, data on Adverse Drug Events (ADE’s), hospital readmissions, and long-run adherence rates among these patients is currently very limited. An integrated MTM platform will allow for tackling these issues and evaluating the impact on IBD patients’ clinical outcomes. Read more from IBD News Today.


Read more about our work with chronically ill patients and their stories.


Learn more about our expectations for this year’s ACG 2016.


See more information about Project A.L.I.V.E. by visiting our IBD page.

Follow us at ACG 2016

Follow Curant Health on Twitter and LinkedIn for our insights at the 2016 American College of Gastroenterology Annual Scientific Meeting in Las Vegas, October 14-19, 2016.


To learn more about our work with IBD patients or to arrange a meeting with our onsite team, please contact Kristin Lindsey, senior director of marketing,